4.6 Review

Current and future use of dried blood spot analyses in clinical chemistry

Journal

CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 51, Issue 10, Pages 1897-1909

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2013-0228

Keywords

dry blood spot; enzyme-linked immunosorbent assay (ELISA); mass spectrometry; polymerase chain reaction (PCR); pre-analytics

Ask authors/readers for more resources

The analysis of blood spotted and dried on a matrix (i.e., dried blood spot or DBS) has been used since the 1960s in clinical chemistry; mostly for neonatal screening. Since then, many clinical analytes, including nucleic acids, small molecules and lipids, have been successfully measured using DBS. Although this pre-analytical approach represents an interesting alternative to classical venous blood sampling, its routine use is limited. Here, we review the application of DBS technology in clinical chemistry, and evaluate its future role supported by new analytical methods such as mass spectrometry.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Blood Biomarkers for Return to Play after Concussion in Professional Rugby Players

Charlotte Oris, Julie Durif, Marion Rouzaire, Bruno Pereira, Damien Bouvier, Samy Kahouadji, Mathieu Abbot, Marina Brailova, Sylvain Lehmann, Christophe Hirtz, Philippe Decq, Bernard Dusfour, Nicola Marchi, Vincent Sapin

Summary: This study evaluated the use of seven blood biomarkers for sport-related concussions. Only S100B and GFAP remained stable over the course of a season. The individual percentage change of S100B and NFL concentrations measured 36 hours after concussion was significantly different between non-resolutive and resolutive cases.

JOURNAL OF NEUROTRAUMA (2023)

Article Biochemistry & Molecular Biology

Does exposure to different menstrual products affect the vaginal environment?

Nicolas Tessandier, Ilkay Basak Uysal, Baptiste Elie, Christian Selinger, Claire Bernat, Vanina Boue, Sophie Grasset, Soraya Groc, Massilva Rahmoun, Bastien Reyne, Noemi Bender, Marine Bonneau, Christelle Graf, Vincent Tribout, Vincent Foulongne, Jacques Ravel, Tim Waterboer, Christophe Hirtz, Ignacio G. Bravo, Jacques Reynes, Michel Segondy, Carmen Lia Murall, Nathalie Boulle, Tsukushi Kamiya, Samuel Alizon

Summary: The study examines the association between the use of different types of menstrual products and microbial, immunological, demographic, and behavioral indicators. The results suggest a potential link between the use of menstrual cups and fungal genital infection, highlighting the possible influence of menstrual products on menstrual health.

MOLECULAR ECOLOGY (2023)

Review Clinical Neurology

Overview of the blood biomarkers in Alzheimer?s disease: Promises and challenges

C. Delaby, C. Hirtz, S. Lehmann

Summary: The increasing number of people with advanced Alzheimer's disease (AD) is a significant burden to the world population. Accurate detection of the earliest phase of preclinical AD is crucial for prevention and therapy. Blood biomarkers have the potential for early and minimally invasive detection of AD, as well as differential diagnosis of dementia and disease monitoring.

REVUE NEUROLOGIQUE (2023)

Article Medical Laboratory Technology

Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF)

Chiara Giangrande, Helene Vaneeckhoutte, Amandine Boeuf, Beatrice Lalere, Christophe Hirtz, Sylvain Lehmann, Milena Quaglia, Vincent Delatour

Summary: The objective of this work is to develop a higher order candidate reference measurement procedure (RMP) for the absolute quantification of t-tau in cerebrospinal fluid. A primary calibrator consisting of a highly purified recombinant protein was sourced to establish metrological traceability. An isotopically-labelled homologue was obtained to develop a candidate RMP by isotope dilution mass spectrometry (IDMS) for t-tau absolute quantification. The candidate RMP has been validated and can be used for global standardization of CSF t-tau measurements.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Article Clinical Neurology

Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis

Mehdi Brousse, Constance Delaby, Elisa De La Cruz, Jens Kuhle, Pascal Benkert, Etienne Mondesert, Nelly Ginestet, Christophe Hirtz, William Camu, Sylvain Lehmann, Florence Esselin

Summary: The study compared the diagnostic performances of two ultrasensitive methods (Ella and Simoa) for the measurement of the neurofilament light chain (NfL) in patients with amyotrophic lateral sclerosis (ALS). Comparable results were obtained from both methods, and cut-off values were proposed for the clinical use of this biomarker.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

New Perspectives of Multiplex Mass Spectrometry Blood Protein Quantification on Microsamples in Biological Monitoring of Elderly Patients

Jerome Vialaret, Margaux Vignon, Stephanie Badiou, Gregory Baptista, Laura Fichter, Anne-Marie Dupuy, Aleksandra Maleska Maceski, Martin Fayolle, Mehdi Brousse, Jean-Paul Cristol, Claude Jeandel, Christophe Hirtz, Sylvain Lehmann

Summary: Blood microsampling combined with large panels of clinically relevant tests is important for the development of home sampling and predictive medicine. This study aimed to demonstrate the practicality and medical utility of microsamples quantification using mass spectrometry (MS) in a clinical setting. The analysis of microsamples allowed the quantification of 62 proteins, with 48 proteins significantly correlated between microsampling plasma and dried blood spot (DBS). This type of analysis opens new perspectives in diagnosis, monitoring, and risk assessment for personalized medicine approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Clinical Neurology

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function

Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sebastien Vidal, Constance Delaby, Frederic Blanc, Claire Paquet, Bernadette Allinquant, Stephanie Bombois, Audrey Gabelle, Olivier Hanon

Summary: Plasma P-tau181 is a diagnostic marker for Alzheimer's disease that effectively detects A beta+ status and conversion to dementia. However, its levels can be influenced by renal function and should be taken into account in the diagnosis.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Dentistry, Oral Surgery & Medicine

Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis

Margaux Vignon, Amandine Bastide, Aurore Attina, Alexandre David, Philippe Bousquet, Valerie Orti, Jerome Vialaret, Sylvain Lehmann, Dominique DevilleDe Periere, Christophe Hirtz

Summary: This study used multiplexed mass spectrometry (MS) to analyze the salivary epitranscriptomic profiles as periodontitis biomarkers. Some nucleosides were found to be significantly altered in periodontitis patients, which may serve as promising biomarkers. This research provides new directions and insights for the discovery of diagnostic biomarkers for periodontitis.

JOURNAL OF PERIODONTAL RESEARCH (2023)

Article Medical Laboratory Technology

Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia

Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sebastien Vidal, Constance Delaby, Frederic Blanc, Claire Paquet, Bernadette Allinquant, Stephanie Bombois, Audrey Gabelle, Olivier Hanon, BALTAZAR Study Grp

Summary: This study compared the clinical performance of Lumipulse and Simoa assays in predicting the conversion to dementia in patients with mild cognitive impairment (MCI). The results showed that both assays had similar abilities, but Lumipulse was less affected by comorbidities. Plasma pTau181 was associated with renal dysfunction, cardiovascular factors, nutrition, and inflammatory markers. The study suggests that Lumipulse could be used as a noninvasive diagnostic tool for the management of Alzheimer's disease.

CLINICAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges

Salome Coppens, Sylvain Lehmann, Christopher Hopley, Christophe Hirtz

Summary: Neurofilament-light chain (Nf-L) is a widely studied biomarker for neurodegenerative diseases (NDD) and traumatic brain injuries (TBI). It can now be measured in blood using ultrasensitive assays, but the development of reliable clinical thresholds and reference measurement procedures (RMP) is crucial for successful clinical implementation. The use of tools like mass spectrometry is ongoing to establish RMP and define the measurand for standardization. This article summarizes the current methods for Nf-L quantification and discusses the progress and challenges in developing RMP and defining the measurand for diagnostic standardization.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medical Laboratory Technology

Use of dried blood spots for monitoring inflammatory and nutritional biomarkers in the elderly

Jerome Vialaret, Margaux Vignon, Christophe Hirtz, Stephanie Badiou, Gregory Baptista, Laura Fichter, Anne-Marie Dupuy, Aleksandra Maleska Maceski, Martin Fayolle, Mehdi Brousse, Jean-Paul Cristol, Claude Jeandel, Sylvain Lehmann

Summary: This study aimed to evaluate the feasibility of using mass spectrometry on dried blood spots (DBS) in a clinical setting. The results showed that mass spectrometry is a reliable method for quantifying protein biomarkers related to nutrition and inflammation. However, there was no correlation between these proteins and patient frailty.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

No Data Available